NewcelX Ltd. (NCEL)
NASDAQ: NCEL · Real-Time Price · USD
3.045
-0.065 (-2.09%)
At close: Oct 9, 2026, 4:00 PM EDT
2.760
-0.285 (-9.36%)
After-hours: Oct 9, 2026, 7:00 PM EDT
NewcelX Market Cap
NewcelX has a market cap or net worth of $17.59 million as of October 9, 2026. It is the 38,071st most valuable company in the world and the 5,319th biggest in the United States.
Market Cap
17.59M
Enterprise Value
17.27M
1-Year Change
n/a
Global Rank
Country Rank
#5,319 United States
Category
ChartMarket Cap Chart
Since October 31, 2025, NewcelX's market cap has decreased from $33.23M to $17.59M, a decrease of -47.07%. That is a compound annual growth rate of -49.19%.
| Date | Market Cap | % Change |
|---|---|---|
| Oct 9, 2026 | 17.59M | 103.08% |
| Dec 31, 2025 | 8.66M | -73.94% |
| Oct 31, 2025 | 33.23M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Akari Therapeutics, | 19.33M |
| Psyence Biomedical | 19.07M |
| Jasper Therapeutics | 18.87M |
| Neuphoria Therapeutics | 18.13M |
| Estrella Immunopharma | 16.53M |
| Marker Therapeutics | 16.23M |
| Dyadic International | 16.20M |
| Kiora Pharmaceuticals | 16.17M |